Stock Snapshot

Market Snapshot

BSE Sensex: 63182.39 0.06%
BSE 500: 25400.02 -0.12%
BSE 200: 8063.67 -0.11%
BSE 100: 19117.93 -0.04%
BSE Mid-Cap: 27612.68 -0.50%
BSE Small-Cap: 31447.9 -0.27%
BANKEX: 50345.67 0.10%
BSE IT Sector: 28944.77 -0.55%
Nifty 50: 18723.35 -0.02%
Nifty 500: 15983.9 -0.14%
Nifty 200: 9838.2 -0.12%
Nifty 100: 18642.15 -0.09%
Nifty Midcap 100: 34284.6 -0.31%
Nifty Small 100: 10501 -0.52%
Nifty IT: 28690.1 -0.77%
Nifty PSU Bank: 4089.6 -0.18%

News:

Spicejet jumps on partnering w...
IndusInd Bank empaneled as age...
Schneider Electric gains on ex...
LIC raises stake in Tech Mahin...
Volumes spurt at One 97 Commun...

Kabra Drugs Ltd BSE
Pharmaceuticals, Small Cap

Invest

05 Jun 2023 | 12:00 AM

5.40

0.00 (0.00%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

41.73%

Return (1Y)

Beaten S&P BSE Sensex by 27.15%
More Volatile

3.98%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 3.19%
Not so consistent

5/11

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Kabra Drugs reports standalone net loss of Rs 0.14 crore in the March 2023 quarter
8 days ago

Kabra Drugs reports standalone net loss of Rs 0.14 crore in the March 2023 quarter

31 - May - 2023 12:00 AM | 8 days ago

Net Loss of Kabra Drugs reported to Rs 0.14 crore in the quarter ended March 2023 as against net loss of Rs 0.06 crore during the previous quarter ended March 2022. There were no Sales reported in the quarter ended March 2023 and during the previous quarter ended March 2022.
For the full year,net loss reported to Rs 0.34 crore in the year ended March 2023 as against net loss of Rs 0.19 crore during the previous year ended March 2022. There were no Sales reported in the year ended March 2023 and during the previous year ended March 2022.
Powered by Capital Market - Live News
Kabra Drugs to discuss results
12 days ago

Kabra Drugs to discuss results

27 - May - 2023 12:00 AM | 12 days ago

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2023.
Powered by Capital Market - Live News
Kabra Drugs reports standalone net loss of Rs 0.06 crore in the December 2022 quarter
113 days ago

Kabra Drugs reports standalone net loss of Rs 0.06 crore in the December 2022 quarter

15 - Feb - 2023 12:00 AM | 113 days ago

Net Loss of Kabra Drugs reported to Rs 0.06 crore in the quarter ended December 2022 as against net loss of Rs 0.04 crore during the previous quarter ended December 2021. There were no Sales reported in the quarter ended December 2022 and during the previous quarter ended December 2021.
Powered by Capital Market - Live News
Kabra Drugs to announce Quarterly Result
121 days ago

Kabra Drugs to announce Quarterly Result

07 - Feb - 2023 12:00 AM | 121 days ago

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2023.
Powered by Capital Market - Live News

Price vs Volume

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Kabra Drugs Ltd BSE Pharmaceuticals, Small Cap

5.40 0.00 (0.00%)

News & Announcements

Price vs Volume

Kabra Drugs Ltd BSE
Pharmaceuticals, Small Cap

5.40

0.00 (0.00%)